AUSTRALIANS are being urged to check if they are eligible for oral COVID-19 antiviral treatments, as part of a Federal Government-funded campaign.
Health Minister, Mark Butler, announced the $11 million program to encourage people to get vaccinated for both COVID-19 and influenza this winter, and promote the availability of prescription medications, Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) through community pharmacies.
"More than 1.3 million courses of antivirals have been purchased by the Government to help protect people who remain at risk of progressing to severe illness from the virus, even when up to date with their vaccinations," the Department said.
"While most of us will only experience mild symptoms, for older Australians and those with some underlying medical conditions antiviral treatments can be effective, often preventing hospitalisation.
"One of the big advantages of these drugs is that they can be taken at home.
"However, timing is critical. COVID-19 can move from mild to severe illness very quickly.
"It's vital to start the five-day antiviral treatment course when symptoms first appear.
"People are encouraged to check if they are eligible for an antiviral treatment and discuss options with their doctor."
Minister Butler added that with both COVID-19 and influenza circulating in the community this winter, it was critical that people ensure they are up to date with the COVID-19 boosters, and make an appointment to have a flu shot if they have yet to get one this year.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jun 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jun 22
